相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Rachael Vaubel et al.
BRAIN PATHOLOGY (2021)
H3 G34-mutant high-grade glioma
Ka Young Lim et al.
BRAIN TUMOR PATHOLOGY (2021)
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Abigail K. Suwala et al.
ACTA NEUROPATHOLOGICA (2021)
Supratentorial ependymoma in childhood: more than just RELA or YAP
Valentina Zschernack et al.
ACTA NEUROPATHOLOGICA (2021)
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
Queenie Hoi-Wing Wong et al.
MODERN PATHOLOGY (2021)
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas
Rui Ryan Yang et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Philipp Sievers et al.
NEURO-ONCOLOGY (2021)
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients
Sebastien Perreault et al.
CURRENT ONCOLOGY (2021)
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant
Charlotte Dufour et al.
BRAIN PATHOLOGY (2020)
An update on the CNS manifestations of brain tumor polyposis syndromes
Byungjin Kim et al.
ACTA NEUROPATHOLOGICA (2020)
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition
Gourish Monday et al.
ACTA NEUROPATHOLOGICA (2020)
Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation
David Castel et al.
ACTA NEUROPATHOLOGICA (2020)
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Scott Ryall et al.
CANCER CELL (2020)
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Matthew Clarke et al.
CANCER DISCOVERY (2020)
Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
Drew Pratt et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas
F. Burel-Vandenbos et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study
Mario Caccese et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical and mutational profiles of adult medulloblastoma groups
Gabriel Chun-Hei Wong et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers
Chang Xu et al.
BIOINFORMATICS (2019)
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma
Joanna J. Phillips et al.
BRAIN PATHOLOGY (2019)
Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis
Norman L. Lehman et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations
William Boisseauc et al.
ONCOLOGIST (2019)
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana S. Guerreiro Stucklin et al.
NATURE COMMUNICATIONS (2019)
Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma
Stefano Indraccolo et al.
CLINICAL CANCER RESEARCH (2019)
Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma
Junji Hosono et al.
WORLD NEUROSURGERY (2019)
Pediatric low-grade gliomas can be molecularly stratified for risk
Rui Ryan Yang et al.
ACTA NEUROPATHOLOGICA (2018)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Mitsuaki Shirahata et al.
ACTA NEUROPATHOLOGICA (2018)
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
Alan Mackay et al.
CANCER CELL (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Adult IDH wild-type lower-grade gliomas should be further stratified
Abudumijit Aibaidula et al.
NEURO-ONCOLOGY (2017)
Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas
Zhenyu Zhang et al.
NEURO-ONCOLOGY (2017)
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
Adrienne Johnson et al.
ONCOLOGIST (2017)
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Pooja Panwalkar et al.
ACTA NEUROPATHOLOGICA (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2017)
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2016)
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
David A. Solomon et al.
BRAIN PATHOLOGY (2016)
The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas
Jantima Tanboon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
Biomarker-based prognostic stratification of young adult glioblastoma
Rui-qi Zhang et al.
ONCOTARGET (2016)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Dominik Sturm et al.
CELL (2016)
Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis
Hadie Adams et al.
CHILDS NERVOUS SYSTEM (2016)
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors
Pierre Bady et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2015)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR
Hui Yang et al.
NATURE PROTOCOLS (2015)
Revisiting TP53 Mutations and Immunohistochemistry-A Comparative Study in 157 Diffuse Gliomas
Hirokazu Takami et al.
BRAIN PATHOLOGY (2015)
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
Aden Ka-Yin Chan et al.
MODERN PATHOLOGY (2015)
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz et al.
NATURE GENETICS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas
Sriram Venneti et al.
BRAIN PATHOLOGY (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Lynn Bjerke et al.
CANCER DISCOVERY (2013)
Gone FISHing: Clinical Lessons Learned in Brain Tumor Molecular Diagnostics over the Last Decade
Craig Horbinski et al.
BRAIN PATHOLOGY (2011)
Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas
Manila Antonelli et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Malignant Gliomas with Primitive Neuroectodermal Tumor-like Components: A Clinicopathologic and Genetic Study of 53 Cases
Arie Perry et al.
BRAIN PATHOLOGY (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Chemotherapy for Malignant Brain Tumors of Childhood
Nicholas G. Gottardo et al.
JOURNAL OF CHILD NEUROLOGY (2008)
分享论文
